Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)

Name: Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)
Published: 2024
License: Public Domain

University Hospital, Caen · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

atrial-fibrillation peritoneal-dialysis randomized-controlled-trial

atrial fibrillation, peritoneal dialysis complication, peritoneal dialysis, anticoagulation, randomized controlled trial, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)

Related documents